HHS Announces Prescription Drug Reforms for Clarity
Table of Contents
New rules aim to provide patients and physicians with real-time access to drug costs and insurance details.
The Department of Health and Human Services (HHS) has announced that prescription drug reforms are scheduled to take effect on October 1. These reforms are designed to give patients and physicians real-time access to prescription drug costs, insurance coverage details, and prior authorization requirements.
According to a Sept. 2 news release from the agency, the rule was issued in July as part of the CMS Inpatient Prospective Payment System and Long-Term Care Hospital Prospective Payment System final rule. It will mandate that healthcare providers utilize certified health IT systems to electronically submit prior authorization requests, check on drug prices during appointments, and share prescription information with pharmacies and insurers.
This change follows a June roundtable that included HHS Secretary Robert F. Kennedy Jr., CMS Administrator Mehmet Oz, MD, Medicare Director Chris Klomp, and representatives from major insurers.
The release stated that insurers have agreed to six reforms aimed at improving transparency and reducing red tape across Medicare Advantage, Medicaid Managed Care, Medicare Part D, ACA Marketplace, and commercial plans.
Insurers agreed to six reforms to improve transparency and reduce red tape.
Understanding the Prescription Drug Reform
Frequently Asked Questions
- What are the main goals of the prescription drug reforms?
- The reforms aim to increase transparency in drug pricing, reduce costs for patients, and streamline the prior authorization process.
- How will these reforms affect healthcare providers?
- Healthcare providers will be required to use certified health IT systems to manage prescriptions and prior authorizations electronically.
- What role did insurers play in these reforms?
- Insurers agreed to six reforms to improve transparency and reduce red tape across various insurance plans.
Sources
